Loading
In some leukaemias the white cell count climbs so high that the cells clog small blood vessels, mostly in the lungs and brain, causing breathlessness, confusion or headache. It is an emergency treated by bringing the count down quickly.
Hyperleukocytosis is usually defined as a white blood cell count above 100,000/µL in acute or chronic leukaemia; it can lead to leukostasis, disseminated intravascular coagulation and tumour lysis syndrome. Leukostasis is end-organ injury from microvascular obstruction by leukaemic blasts, a clinical diagnosis that can also occur at counts below 100,000/µL, with pulmonary, renal and cerebral involvement the commonest presentations. Supportive care includes intravenous hydration, uric acid-lowering drugs and cautious transfusion, since raising blood viscosity can worsen leukostasis. Hydroxyurea and cytarabine are used to lower the count before definitive induction chemotherapy; the benefit of leukapheresis on early outcomes has not been definitively shown and practice varies.
Showing the molecule this term concerns: Hydroxyurea (hydroxycarbamide).
Shares Cytarabine, Acute myeloid leukaemia and the tag supportive-care-gaps-2026-11.
Shares Acute myeloid leukaemia and the tag supportive-care-gaps-2026-11.
Shares Tumour lysis syndrome (TLS), Hydroxyurea (hydroxycarbamide), Cytarabine, Acute myeloid leukaemia.
Shares Cytarabine, Acute myeloid leukaemia.
Shares Cytarabine, Acute myeloid leukaemia.
Shares Tumour lysis syndrome (TLS), Acute myeloid leukaemia.
Shares Cytarabine, Acute myeloid leukaemia.
Shares Cytarabine, Acute myeloid leukaemia.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/